ClinicalTrials.gg
RecruitingNCT05700201I - CHATUpdated Aug 6, 2026

Investigating Cardiac Health of Adults With Trauma

An interventional study of Lifestyle / Healthy Behavior Intervention and standard care in Posttraumatic Stress Disorder, sponsored by Nova Southeastern University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by Nova Southeastern University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2023; still recruiting 3 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
216
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This project examines the impact of a healthy lifestyle intervention, specifically designed for adults with posttraumatic stress and identified cardiovascular risks.

Read the detailed description

Considerable research has indicated strong associations between posttraumatic stress and cardiovascular disease (CVD) risk. Individuals with posttraumatic stress disorder (PTSD) tend to show patterns of elevated CVD risk earlier in life than in the general population. The need for developing effective interventions for CVD risk-reduction in PTSD is increasingly evident. In comparison to the cumulative evidence concerning elevated CVD risk in PTSD, relatively little research has addressed CVD risk-reduction in this population. Adjunctive treatments, such as health behavior interventions, may be necessary as supplements to traditional psychotherapy for PTSD in order to reduce CVD risks. The objective of the proposed project is to examine the effects of a healthy lifestyle intervention that addresses multiple CVD-related heath behaviors among civilian adults across genders (ages 18+), who evidence PTSD and CVD risk at baseline. The investigators will assess the intervention impact on both subjective and objective indices of health behaviors, cardiovascular risks and CVD markers over a one-year timeframe. The healthy lifestyle intervention addresses unique aspects of PTSD symptom presentation that serve as barriers to healthy behaviors (e.g., nightmares/sleep disruption, and cognitive responses to stress), while encouraging healthy lifestyle changes. The primary goal of the present study is to examine whether, compared to a usual care psychotherapy control condition, utilizing the healthy lifestyle intervention as an adjunct to psychotherapy will result in significantly reduced CVD risks and improved CVD markers among civilian adults with PTSD and elevated CVD risks. Therefore, participants will be randomly assigned to either a usual care psychotherapy-only control condition or a usual care psychotherapy plus healthy lifestyle intervention condition. Outcomes will be assessed at post-intervention (12 weeks), as well as 6-month and 12-month time points for follow-up evaluation.

02

Conditions studied

  • Posttraumatic Stress Disorder

Keywords

  • Posttraumatic Stress
  • Cardiovascular
  • Health
  • Intervention
  • PTSD
  • Lifestyle
  • Behavior
03

In context

Stress Disorders, Post-Traumatic

2,682 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 601 are open to participants now.

This study's planned enrollment of 216 is above the median of 69 across 2,196 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Nova Southeastern University is the lead sponsor of 80 studies on the registry; 18 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • PTSD symptoms
  • overweight OR less than 30 min. of moderate physical activity 5 times per week

Exclusion criteria

Exclusion Criteria:

  • cannot exercise at a low-moderate level (walking)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
216 participants (estimated)

Study arms

  • Experimental
    Intervention

    Healthy lifestyle intervention

    Behavioral: Lifestyle / Healthy Behavior Intervention

  • Experimental
    Control

    Standard care (psychotherapy)

    Other: standard care

Interventions

  • BehavioralLifestyle / Healthy Behavior Intervention

    12-session healthy lifestyle program focused on physical activity, nutrition, sleep, and stress management.

  • Otherstandard care

    Standard care (psychotherapy)

06

What researchers measure

Primary outcomes

  1. Physical activity

    The International Physical Activity Questionnaire (7-Day long form) is a reliable and valid measure that will be used to assess time spent in a variety of moderate and vigorous activities in the past week

    Time frame: 1 year

Secondary outcomes

  1. Arterial Stiffness

    non-invasive measurement of augmentation index, calculated as the difference between the second and the first systolic peaks and expressed as percentage of the central aortic pulse pressure

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • College of Psychology, Nova Southeastern University
    Fort Lauderdale, Florida 33314, United States
    Recruiting
    • Jeffrey Kibler, PhD · Contact
    • Jeffrey Kibler, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05700201
Lead sponsor
Nova Southeastern University
Responsible party
Jeffrey Kibler, Ph.D. (Professor, Nova Southeastern University) — Principal investigator
First posted
Jan 26, 2023
Start date
Apr 21, 2023
Primary completion
Aug 31, 2026 (estimated)
Completion
Aug 31, 2026 (estimated)
Last update
Aug 6, 2026

Study contacts

Shay Murphy
Contact
whs.nsu@gmail.com
954-262-5942
Jeffrey Kibler, PhD
Contact
kibler@nova.edu
Jeffrey Kibler, PhD
principal investigator · Nova Southeastern University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion